|  Help  |  About  |  Contact Us

Publication : The Paget's disease of bone risk gene PML is a negative regulator of osteoclast differentiation and bone resorption.

First Author  Wani S Year  2022
Journal  Dis Model Mech Volume  15
Issue  4 PubMed ID  35229101
Mgi Jnum  J:325618 Mgi Id  MGI:7275322
Doi  10.1242/dmm.049318 Citation  Wani S, et al. (2022) The Paget's disease of bone risk gene PML is a negative regulator of osteoclast differentiation and bone resorption. Dis Model Mech 15(4):dmm049318
abstractText  Paget's disease of bone (PDB) is characterized by focal increases in bone remodelling. Genome-wide association studies identified a susceptibility locus for PDB tagged by rs5742915, which is located within the PML gene. Here, we have assessed the candidacy of PML as the predisposing gene for PDB at this locus. We found that the PDB-risk allele of rs5742915 was associated with lower PML expression and that PML expression in blood cells from individuals with PDB was lower than in controls. The differentiation, survival and resorptive activity of osteoclasts prepared from Pml-/- mice was increased compared with wild type. Furthermore, the inhibitory effect of IFN-gamma on osteoclast formation from Pml-/- was significantly blunted compared with wild type. Bone nodule formation was also increased in osteoblasts from Pml-/- mice when compared with wild type. Although microCT analysis of trabecular bone showed no differences between Pml-/- mice and wild type, bone histomorphometry showed that Pml-/- mice had high bone turnover with increased indices of bone resorption and increased mineral apposition rate. These data indicate that reduced expression of PML predisposes an individual to PDB and identify PML as a novel regulator of bone metabolism. This article has an associated First Person interview with the first author of the paper.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

0 Expression